Stay updated on Alvelestat in alpha1-antitrypsin COPD: Clinical Trial
Sign up to get notified when there's something new on the Alvelestat in alpha1-antitrypsin COPD: Clinical Trial page.

Latest updates to the Alvelestat in alpha1-antitrypsin COPD: Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThis update reflects a change to the ClinicalTrials.gov page/version revision label (from v3.5.0 to v3.5.3), indicating a site release rather than a change to the study record itself.SummaryDifference0.1%

- Check45 days agoChange DetectedUpdated the terminology to 'Alpha-1-antitrypsin deficiency' to ensure consistent hyphenation with 'Alpha-1' across the page.SummaryDifference0.0%

- Check53 days agoChange DetectedSite revision updated to v3.5.0, replacing the previous v3.4.3.SummaryDifference0.0%

- Check67 days agoChange DetectedSite version updated from v3.4.2 to v3.4.3; no visible changes to study details or page content.SummaryDifference0.0%

- Check89 days agoChange DetectedOnly the site’s revision label was updated from v3.4.1 to v3.4.2; there are no visible changes to the page content or features. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check96 days agoChange DetectedRevision numbers on the page were updated: added v3.4.1 and removed v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Alvelestat in alpha1-antitrypsin COPD: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Alvelestat in alpha1-antitrypsin COPD: Clinical Trial page.